Related Experiment Videos
Acquired immune deficiency syndrome-related Kaposi's sarcoma
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Management of Kaposi sarcoma: the role of interferon and thalidomide.
Current opinion in oncology·2001
Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Clinical overview: issues in Kaposi's sarcoma therapeutics.
Journal of the National Cancer Institute. Monographs·1998
Phase I/II trial of the type I soluble recombinant human interleukin-1 receptor in HIV-1-infected patients.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·1998
Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·1998
AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
The Patient Who Could Not Die.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.
Frontiers in oncology·2026